Purchase disclosed
Michael R. Hayden
Director
Common Shares
- Reported value
- $570.44K
- Reported price
- $10.64 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
AbCellera Biologics Inc.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 13 trades on this page.
Director
Common Shares
Director
Common Shares
Chief Financial Officer
Common Shares
Director
Common Shares
Director
Common Shares
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
Director
Share option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Share option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Share option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Share option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Share option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Financial Officer
The filed price or value is unverified and is excluded from totals and purchase scores.
Common Shares
Filing error, value unverified. The filed amounts are preserved for review and excluded from buying signals and transaction totals until verified.
Chief Financial Officer
Share option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Shares
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common SharesPurchase | 53,613$10.64 / share | $570.44K | Aug 24Filed Aug 24 · 0d later | SEC filing |
| Director | Common SharesPurchase | 10,000$11.03 / share | $110.3K | Aug 18Filed Aug 18 · 0d later | SEC filing |
| Chief Financial Officer | Common SharesPurchase | 37,200$10.32 / share | $383.9K | Aug 14Filed Aug 14 · 0d later | SEC filing |
| Director | Common SharesPurchase | 46,387$10.37 / share | $481.03K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Director | Common SharesGift | 50,000Gift · no purchase price | Not a purchase | Aug 11Filed Aug 13 · 2d later | SEC filing |
| Director | Share option (right to buy)Grant or award | Derivative units152,207Award · no purchase price | Non-cash award | Jul 1Filed Jul 6 · 5d later | SEC filing |
| Director | Share option (right to buy)Grant or award | Derivative units152,207Award · no purchase price | Non-cash award | Jul 1Filed Jul 6 · 5d later | SEC filing |
| Director | Share option (right to buy)Grant or award | Derivative units111,701Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Share option (right to buy)Grant or award | Derivative units111,701Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Share option (right to buy)Grant or award | Derivative units111,701Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
Chief Financial OfficerFiling error, value unverifiedThe filed price or value is unverified and is excluded from totals and purchase scores.
| Common SharesOption exercise or conversion | 250,000— | — | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Chief Financial Officer | Share option (right to buy)Option exercise or conversion | Derivative units250,000$0.19 exercise / conversion price | Not a separate purchase | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesPurchase | 20,000$4.77 / share | $95.4K | May 14Filed May 18 · 4d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
$1,183,110 of common-equity purchase value after transaction-age decay across 180 days.
3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.